Full Press Release Details
lives by improving patient care through communication, accuracy, reliability and efficiency. That commitment aligns closely with PPD's mission and purpose to help its customers deliver life-changing therapies that improve health." As a premier cancer diagnostics and pharma services company, NeoGenomics has a network of CAP-accredited (College of American Pathologists), CLIA-licensed (Clinical Laboratory Improvement Amendments) facilities across the U.S. About PPD PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 47 countries and approximately 20,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health. For more information, visit www.ppdi.com. About NeoGenomics, Inc. NeoGenomics, Inc. specializes in cancer genetics testing and information services. The company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The company's pharma services division serves pharmaceutical clients in clinical trials and drug development. Headquartered in Fort Myers, Florida, NeoGenomics operates CLIA-certified laboratories in Aliso Viejo and Fresno, California; Tampa and Fort Myers, Florida; Houston, Texas; Nashville, Tennessee; and Rolle, Switzerland. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks and managed care organizations throughout the United States. For additional information about NeoGenomics, visit http://neogenomics.com. PPD Contacts Media: Randy Buckwalter +1 919 456 4425 randy.buckwalter@ppdi.com Investors: Nate Speicher +1 910 558 6783 nate.speicher@ppdi.com NeoGenomics Contact Bill Bonello +1 239 690 4238 bill.bonello@neogenomics.com 2